Is America moving toward the same healthcare problems facing Canada?

Dr. Jay Goldberg, North American Affairs Manager at the Consumer Choice Center, joins Andrew Langer on the Washington Signal's Lunch Hour to examine the growing role of government in healthcare, the importance of consumer choice, and the consequences of policies that restrict competition.

A political scientist with undergraduate and doctoral degrees from the University of Toronto, Goldberg brings a Canadian perspective to the debate over American healthcare policy. He explains how Canada's government-funded healthcare system has contributed to lengthy wait times, physician shortages, and challenges attracting and retaining medical professionals.

The conversation begins by examining the difference between health insurance and healthcare itself. Goldberg argues that confusing the two can lead to policies that prioritize controlling expenditures over improving patient access and outcomes.

Andrew and Jay also discuss the financial pressures facing physicians, including medical school debt, reimbursement rates, and the costs of operating a medical practice. Goldberg shares examples from Canada to illustrate how government payment systems can affect physicians' decisions about where to practice medicine.

The discussion then turns to pharmaceutical innovation and the growing popularity of GLP-1 medications. Goldberg examines how competition between drug manufacturers can lower prices, why government subsidies may obscure the actual costs of treatment, and how pricing policies could affect the development and availability of new medicines.

They also explore the federal 340B Drug Pricing Program, the Trump administration's proposed Most Favored Nation approach to pharmaceutical pricing, and the potential consequences of tying American drug prices to those paid in other countries.

Throughout the conversation, Goldberg emphasizes the importance of market competition, consumer choice, and policies that encourage medical innovation rather than discourage investment.

Finally, the discussion moves beyond healthcare to energy policy. With artificial intelligence and data centers driving growing electricity demand, Goldberg makes the case for an energy-abundance strategy that includes oil, natural gas, nuclear power, and economically viable renewable energy sources.

Can the United States expand healthcare access, lower costs, and maintain its leadership in medical innovation without sacrificing consumer choice?

Join Andrew Langer and Dr. Jay Goldberg for a discussion about healthcare reform, pharmaceutical competition, and the policies shaping the future of American consumers.

00:00 - Introduction to Dr. Jay Goldberg

01:47 - What Is the Consumer Choice Center?

03:06 - Healthcare vs. Health Insurance: Why the Difference Matters

05:23 - Physician Shortages and Canada's Healthcare System

09:00 - Medical School Debt and Government Reimbursement

13:20 - GLP-1 Drugs, Medicare and Government Subsidies

15:04 - Drug Prices, Copays and Pharmaceutical Competition

20:59 - Why Competition Matters Across Industries

24:45 - The 340B Drug Pricing Program

26:51 - Most Favored Nation Drug Pricing and Patient Access

30:24 - Energy Abundance, Data Centers and America's Energy Future

Follow us on social media

X: @TheLunchHourPod

Instagram: the_lunchhour_pod

LinkedIn: Lunch Hour Podcast

TikTok: lunchhourpod

Find more at Washington Signal

Your source for policy, national security, and investigative journalism.

https://washingtonsignal.com/